Goat Anti-Bag-1 (K-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Treponema Pallidum IgM ELISA Kit, Single from Bio-Quant Inc.
Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.
Gel Loading Dye (Bromophenol Blue/Glycerol) from Mo Bio Laboratories, Inc.
Biology Products:(Date:12/2/2009)... one of your muscles can twitch, before the though...iny floodgate of sortscalled an ion channelmust op...let in the chemical signals that spur the cell to ... Standards and Technology (NIST) has allowed scien...embrane for the first time, potentially offering i...
(Date:12/2/2009)..., NY, December 2, 2009 Commonly prescribed beta 2...hma in pregnant women as well as pre-term labor ma...ers, psychiatric pathology, cognitive problems and...ing to a new study published in the December 2009 ...ecology . , Beta 2 adrenergic agonist drugs as a...
(Date:12/2/2009)...Hall, a PhD student at the University of Southampt...he National Oceanography Centre, Southampton (NOCS...crab, all from the deep sea. , Hall discovered t...he National Museum of Natural History in Washingto...id: "King crabs include some of the largest crusta...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2King crab family bigger than ever 2Authentidate Holding Corp to Report Fiscal 2010 First Quarter Results on Monday November 16 2009 61295 1Authentidate Holding Corp to Report Fiscal 2010 First Quarter Results on Monday November 16 2009 61295 2Soligenix Reports Third Quarter 2009 Financial Results 14827 1Soligenix Reports Third Quarter 2009 Financial Results 14827 2Soligenix Reports Third Quarter 2009 Financial Results 14827 3Soligenix Reports Third Quarter 2009 Financial Results 14827 4Soligenix Reports Third Quarter 2009 Financial Results 14827 5Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement 6245 1Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement 6245 2... biodegradable polymers called polyketals and thei...mmatory illnesses as acute lung injury, acute live...ring drugs, proteins and snips of ribonucleic acid...al microparticles we developed are simply a vehicl... area as quickly as possible," said Niren Murthy, ...
...l Human Genome Research Institute (NHGRI), part of...arded more than $20 million in grants to develop i...efficient enough to sequence a person,s DNA as a r.... , "The ability to comprehensively sequence any...d to usher in an age of personalized medicine wher...
...to unravel gonadotrophs , Although the basic de...nown, it has been harder to associate specific cha... limited cell population. In an article on p. 546 ...uction , Feng et al. take the approach of comparin...nes that were immortalized at different stages of ...
Other Biology News:Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 2NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 5September 2008 Biology of Reproduction highlights 2(Date:12/2/2009)... Peregrine Pharmaceutical... of patient enrollment in a dose confirmation and ...elapsed glioblastoma multiforme (GBM), the deadlie...oclonal antibody linked to a radioisotope being de...ara specifically targets cells at the center of br...
(Date:12/2/2009)...ands, December 2 Pepscan Holding N...using on protein mimicking,technology for the gene... it,has appointed Wim E.M. Mol, Ph.D. as new Chief...ponsible for all of Pepscans corporate functions a...of the company. He brings to,Pepscan more than 20 ...
(Date:12/2/2009)...RNewswire/ -- S*BIO Pte Ltd today announced data p...518, at The American Society of Hematology 51st An...Data will be presented on the clinical results fro...iling its safety, tolerability and pharmacokinetic...nging from 100 to 600 mg. These doses were adminis...
(Date:12/2/2009)...swire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ...rmaceutical company focused on endocrine therapy a...d Drug Administration (FDA) has granted Fast Track...hibitor compound, perifosine (KRX-0401), for the t...Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3